Literature DB >> 12540527

Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.

Regina Gisbert1, Yolanda Madrero, Valentina Sabino, M Antonia Noguera, M Dolores Ivorra, Pilar D'Ocon.   

Abstract

1. The alpha(1)-adrenergic responses of rat aorta and tail artery have been analysed measuring the contractility and the inositol phosphate (IP) formation induced by noradrenaline. Three antagonists, prazosin, 5-methylurapidil (alpha(1A) selective) and BMY 7378 (alpha(1D) selective) have been used in different experimental procedures. 2. Noradrenaline possesses a greater potency inducing contraction and IP accumulation in aorta (pEC(50)-contraction=7.32+/-0.04; pEC(50)-IPs=6.03+/-0.08) than in the tail artery (pEC(50)-contraction=5.71+/-0.07; pEC(50)-IPs=5.51+/-0.10). Although the maximum contraction was similar in both tissues (E(max)-tail=619.1+/-55.6 mg; E(max)-aorta-698.2+/-40.8 mg), there were marked differences in the ability of these tissues to generate intracellular second messengers the tail artery being more efficient (E(max)-tail=1060+/-147%; E(max)-aorta=108.1+/-16.9%). 3. Concentration response curves of noradrenaline in presence of antagonist together with concentration inhibition curves for antagonists added before (CICb) or after (CICa) noradrenaline-induced maximal response in Ca(2+)-containing or Ca(2+)-free medium have been performed. A comparative analysis of the different procedures as well as the mathematical approaches used in each case to calculate the antagonist potencies, were completed. 4. The CICa was the simplest method to characterize the predominant alpha(1)-adrenoceptor subtype involved in the functional response of a tissue. 5. In aorta, where constitutively active alpha(1D)-adrenoeptors are present, the use of different experimental procedures evidenced a complex equilibrium between alpha(1D)- and alpha(1A)-adrenoceptor subtypes. 6. The appropriate management of LiCl in IP accumulation studies allowed us to reproduce the different experimental procedures performed in contractile experiments giving more technical possibilities to this methodology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540527      PMCID: PMC1573663          DOI: 10.1038/sj.bjp.0705033

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.

Authors:  S Murata; T Taniguchi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Modulatory role of a constitutively active population of alpha(1D)-adrenoceptors in conductance arteries.

Authors:  Khalid Ziani; Regina Gisbert; Maria Antonia Noguera; Maria Dolores Ivorra; Pilar D'Ocon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

Review 3.  Alpha1-adrenergic receptors: new insights and directions.

Authors:  M T Piascik; D M Perez
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats.

Authors:  Regina Gisbert; Khalid Ziani; Raquel Miquel; M Antonia Noguera; M Dolores Ivorra; Elsa Anselmi; Pilar D'Ocon
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Functional evidence of a constitutively active population of alpha(1D)-adrenoceptors in rat aorta.

Authors:  R Gisbert; M A Noguera; M D Ivorra; P D'Ocon
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

7.  Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists.

Authors:  D F McCune; S E Edelmann; J R Olges; G R Post; B A Waldrop; D J Waugh; D M Perez; M T Piascik
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

8.  Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes.

Authors:  Dan Chalothorn; Dan F McCune; Stephanie E Edelmann; Mary L García-Cazarín; Gozoh Tsujimoto; Michael T Piascik
Journal:  Mol Pharmacol       Date:  2002-05       Impact factor: 4.436

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more
  7 in total

1.  Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice.

Authors:  Clare Deighan; Laura Methven; Mustafa M Naghadeh; Alexis Wokoma; Joyce Macmillan; Craig J Daly; Akito Tanoue; Gozoh Tsujimoto; John C McGrath
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

2.  Activation of α1A -adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing.

Authors:  Cristina Arce; Diana Vicente; Vanessa Segura; Nicla Flacco; Fermi Montó; Luis Almenar; Jaime Agüero; Joaquín Rueda; Francesc Jiménez-Altayó; Elisabet Vila; Maria Antonia Noguera; Pilar D'Ocon; Maria Dolores Ivorra
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

3.  Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

Authors:  Z Nourian; T Mow; D Muftic; S Burek; M L Pedersen; J Matz; M J Mulvany
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

4.  Smooth muscle alpha1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles.

Authors:  W F Jackson; E M Boerman; E J Lange; S S Lundback; K D Cohen
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

5.  Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding.

Authors:  Takashi Tanaka; Li Zhang; Fumiko Suzuki; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

6.  Alpha-1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery.

Authors:  Naoyuki Taki; Takashi Tanaka; Li Zhang; Fumiko Suzuki; Malika Israilova; Takanobu Taniguchi; Yasuko Hiraizumi-Hiraoka; Kazumasa Shinozuka; Masaru Kunitomo; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

7.  α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.

Authors:  Nicla Flacco; Jaime Parés; Eva Serna; Vanessa Segura; Diana Vicente; Miguel Pérez-Aso; María Antonia Noguera; María Dolores Ivorra; John C McGrath; Pilar D'Ocon
Journal:  Pharmacol Res Perspect       Date:  2013-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.